Citation: | HOU Fenghui, DUAN Lizhi, YU Li, WU Huimin. Expression of serum lipoprotein and high sensitivity C-reactive protein in serum of patients with type 2 diabetic nephropathy and its clinical significance[J]. Journal of Clinical Medicine in Practice, 2014, (17): 33-35. DOI: 10.7619/jcmp.201417010 |
Shide K, Takada Y, Nakashima A. Patients′Percep-tion on the Nutritional Therapy for Diabetic Nephropathy [J]. Japanese clinical medicine, 2014.9.
|
Choudhary N, Ahlawat R S. Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy:new evidence linking inflammation, glycemic control, and microalbuminuria [J]. Iranian journal of kidney diseases, 2008(2):72.
|
Nath I, Nath C K, Baruah M. A Study of Inflamma-tory Status in Nephropathy Patients with History of Type-II Diabetes Mel itus Undergoing Haemodialysis [J]. J Clin Diagn Res, 2013, (10):2143.
|
Del Caizo Gó mez F J, Ferná ndez Pé rez C, Moreno Ruiz I. Microvascular complications and risk factors in patients with type 2 diabetes [J]. Endocrinología y Nutrición, 2011(4):163.
|
Shelbaya S, Amer H, Seddik S. Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabet-ic nephropathy in type 1 diabetic patients [J]. European Review for Medical and Pharmacological Science, 2012(2):176.
|
Fu C C, Wu D A, Wang J. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chi-nese type 2 diabetic patients [J]. ACTA DIABETOLOGICA, 2009(2):127.
|
Chandni R, Ramamoorthy K P. Lipoprotein (a)in type 2 di-abetic subj ects and its relationship to diabetic microvascular complications [J]. World journal of diabetes, 2012(5):105.
|
林浩, 熊石龙. 2型糖尿病肾病患者血清脂蛋白(a)和超敏C反应蛋白的变化及其相关性分析 [J]. 中南医学科学杂志, 2013(4):375.
|
Wan Z M, Chen W Y, Lu M L. Higher procalcitonin level in diabetic nephropathy patients compared with healthy volunteers [J]. Journal of Sichuan University, 2014(3):442.
|
贾利敏. 糖尿病肾病患者脂蛋白a变化的研究 [J]. 现代中西医结合杂志, 2014(7):769.doi: 10.3969/j.issn.1008-8849.2014.07.040.
|